Navigation Links
Rat Adrenal from Pel-Freez Biologicals

ProductsRat Adrenal from Pel-Freez Biologicals
Company Pel-Freez Biologicals
Item Rat Adrenal
Price $85.00
Description Sprague-Dawley rats, 7-8 weeks old, mixed gender; tissue is collected fresh, frozen on dry ice within minutes of sacrifice and stored at -20C; individual tissue weight approx. 0.05 gram.
Info Pel-Freez BiologicalsPel-Freez Biologicals
P.O. Box 68
Rogers, AR 72757

Call Pel-Freez Biologicals to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-808-7264
Customer Service: (800) 643-3426 or (479) 636-4361
Fax Number: (479) 636-3562
Web Site: http://www.pelfreez-bio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Rabbit Serum Non-Hemolyzed, Sterile, Delipidized from Pel-Freez Biologicals
2. Rat Whole Blood Non-Sterile Alsevers from Pel-Freez Biologicals
3. Bovine Calf Blood Non-Sterile Alsevers from Pel-Freez Biologicals
4. Guinea Pig Complement from Pel-Freez Biologicals
5. Mouse Complement from Pel-Freez Biologicals
6. Rabbit Complement from Pel-Freez Biologicals
7. Rabbit Complement from Pel-Freez Biologicals
8. 3-4 Week Baby Rabbit Complement Sterile from Pel-Freez Biologicals
9. Rat Plasmin from Pel-Freez Biologicals
10. Rat Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
11. Dog Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
...
Water Distilled (Gibco™) is membrane filtered and endotoxin screened....
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products:
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... NEWS SERVICE, Weekly Press Package, November 14, 2007 ... Service Weekly press package (PressPac) with reports selected from ... With more than 160,000 members, ACS is ... journal, or the American Chemical Society, as the source ...
... nanoparticles that, when pulsed with an electromagnetic field, release ... Nov. 15 online issue of Advanced Materials, could lead ... In earlier work the team, led by Sangeeta ... of Health Sciences & Technology (HST) and in MIT,s ...
... 16, 2007) -- Honeybees somehow manage to efficiently collect a ... after all, the queen bee is too busy ... best nectar can be found on any given morning. According ... swarm intelligence of these amazingly organized bees can also be ...
Cached Biology News:American Chemical Society's Weekly PressPac -- Nov. 14, 2007 2American Chemical Society's Weekly PressPac -- Nov. 14, 2007 3American Chemical Society's Weekly PressPac -- Nov. 14, 2007 4American Chemical Society's Weekly PressPac -- Nov. 14, 2007 5American Chemical Society's Weekly PressPac -- Nov. 14, 2007 6American Chemical Society's Weekly PressPac -- Nov. 14, 2007 7American Chemical Society's Weekly PressPac -- Nov. 14, 2007 8American Chemical Society's Weekly PressPac -- Nov. 14, 2007 9American Chemical Society's Weekly PressPac -- Nov. 14, 2007 10MIT: Remote-control nanoparticles deliver drugs directly into tumors 2Bee strategy helps servers run more sweetly 2Bee strategy helps servers run more sweetly 3
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
(Date:2/27/2015)... Cytokinetics, Incorporated (Nasdaq: CYTK) announced today ... patients and health care advocates in the United States ... Rare Disease Day is dedicated to elevating public ... special challenges faced by patients with rare diseases and ... to stand alongside patients and caregivers representing the rare ...
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... , Feb. 26, 2015 On behalf of ... affiliated companies, Wilentz, Goldman & Spitzer, P.A. ... lawsuit against Genewiz Inc. in excess of $10 million. ... GenScript,s trade secrets, and that it improperly hired one ... order denying motions for judgment notwithstanding the verdict, a ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3